Timing of referral for lung transplantation for cystic fibrosis: Overemphasis on FEV1 may adversely affect overall survival

Chest

Volumn 115, Issue 3, 1999, Pages 782-787

  Doershuk, Carl F ^a,b   Stern, Robert C ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

Cystic fibrosis; FEV1; Lung transplant; Survival

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CYSTIC FIBROSIS; DISEASE CLASSIFICATION; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG TRANSPLANTATION; MALE; PATIENT REFERRAL; PATIENT SELECTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SCHOOL CHILD; SURVIVAL;

EID: 0033032660     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.115.3.782     Document Type: Article

References (21)

1. 1 Davis PB, Drumm M, Konstan MW. State of the art: cystic fibrosis. Am J Respir Crit Care Med 1996; 154:1229-1256
2. 2 Trulock EP. State of the art: lung transplantation. Am J Crit Care Med 1997; 155:789-818
3. 3 Ryan PJ, Stableforth DE. Referral for lung transplantation: experience of a Birmingham adult cystic fibrosis centre between 1987 and 1994. Thorax 1996; 51:302-305
4. 4 Cooper H. St. Louis international lung transplant registry. St. Louis, MO: Washington University School of Medicine, 1997.
5. 5 Kerem E, Reisman J, Corey M, et al. Prediction of mortality in patients with cystic fibrosis. N Engl J Med 1992; 326:1187-1191
6. 6 Grasemann H, Wiesemann HG, Ratjen F. The importance of lung function as a predictor of 2-year mortality in mucoviscidosis. Pneumologie 1995; 49:466-469
7. 7 Milla CE, Warwick WJ. Risk of death in cystic fibrosis patients with severely compromised lung function. Chest 1998; 113:1230-1234
8. 8 American Thoracic Society. Standardization of spirometry. Am Rev Respir Dis 1979; 119:831-838
9. 9 Taussig LM, Chernick V, Wood R, et al. Standardization of lung function testing in children: recommendations of the GAP Conference Committee, Cystic Fibrosis Foundation. J Pediatr 1980; 97:668-676
10. 10 Knudson RJ, Lebowitz MD, Holberg CJ, et al. Changes in the normal expiratory flow-volume curve with growth and aging. Am Rev Respir Dis 1983; 127:725-734
11. 11 Hosenpud JD, Novick RJ, Breen TJ, et al. The registry of the international society for heart and lung transplantation: 12th official report-1995. J Heart Lung Transplant 1995; 14:805-815
12. 12 Egan T, Detterbeck F, Mill M, et al. Improved results of lung transplantation for patients with cystic fibrosis. J Thorac Cardiovasc Surg 1995; 109:224-235
13. 13 Ramirez J, Patterson G, Winton T, et al. Bilateral lung transplantation for cystic fibrosis. J Thorac Cardiovasc Surg 1992; 103:287-294
14. 14 Shennib H, Noirclerc M, Ernst P, et al. Double-lung transplantation for cystic fibrosis. Ann Thorac Surg 1992; 54:27-32
15. 15 Konishi H, Komatsu K, Bando K, et al. Bilateral lung transplantation for cystic fibrosis: University of Pittsburgh experience. J Heart Lung Transplant 1993; 12:S69
16. 16 Snell G, de Hoyos A, Krajden M, et al. Pseudomonas cepacia in lung transplantation recipients with cystic fibrosis. Chest 1993; 103:466-471
17. 17 Griffith B, Hardesty R, Armitage H, et al. A decade of lung transplantation. Ann Surg 1993; 218:310-320
18. 18 Wegener JS, Taussig LM, Burrows B, et al. Comparison of lung function and survival patterns between cystic fibrosis and emphysema or chronic bronchitis patients. In: Sturgess JM, ed. Perspectives in cystic fibrosis: Proceedings of the Eighth International Cystic Fibrosis Conference, Toronto, May 26-30, 1980. Toronto: Canadian Cystic Fibrosis Foundation, 1980; 236-245
19. 19 Kotloff RM, Zuckerman JB. Lung transplantation for cystic fibrosis: special considerations. Chest 1996; 109:787-798
20. 20 American Thoracic Society. International guidelines for the selection of lung transplant candidates. Am Rev Respir Crit Care Med 1998; 158:335-339
21. 21 Flume PA. Cystic fibrosis: when to consider lung transplantation? Chest 1998; 113:1159-1161